BETHESDA, Md. (AP) _ Northwest Biotherapeutics Inc. (NWBO) on Wednesday reported a loss of $21.5 million in its first quarter.
The Bethesda, Maryland-based company said it had a loss of 9 cents per share. Losses, adjusted for one-time gains and costs, came to 6 cents per share.
The cancer drug developer posted revenue of $132,000 in the period.
The company's shares closed at 21 cents. A year ago, they were trading at 16 cents.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NWBO at https://www.zacks.com/ap/NWBO